期刊文献+

吴康衡教授辨治过敏性紫癜经验 被引量:6

Experience to Treat Allergic Purpura of Professor WU Kang-heng
下载PDF
导出
摘要 过敏性紫癜是由免疫复合物介导的免疫性疾病,病理改变以全身小血管炎症为主。临床表现为臀部、双下肢伸侧面紫红色针尖至米粒大小出血斑,指压不褪色。多数病人伴有以腹痛为主的消化道症状及关节疼痛,后期病程进展多影响到肾,以血尿、蛋白尿为突出表现。西医采用激素、抗组胺、改善血管通透性等药对控制急性症状效果较理想,由于本病为系统性免疫疾病,临床及实验研究发现多数患者存在免疫功能紊乱、激素耐药及不良反应等,该病常易复发,且有研究报道,多次或持续的紫癜或腹痛可能为过敏性紫癜向肾病发展的相关性因素。吴康衡教授运用中医药治疗过敏性紫癜疗效显著,现介绍如下。 Allergic purpura is a immune disease mediated by immune complex. Pathological changes primarily performances small blood vessel inflammation. Clinical manifests with Stretch of lower limbs side purple bleeding spot, the size between needlepoint and rice, and not fading when depressing the skin. Most patients have the enteron symptom of abdominal pain and joint pain, later it can influnce the kidney, which manifested with Hematuria and albuminuria.Western medicine have excellent effects to control the acute syndromes with hormone antihistamine and improving the vascular permeability. Clinical and experimental studies found most patient have Immune dysfunction, hormone resistance and adverse reactions, so this disease often relapses. Study reports that the continuing purpura or abdominal pain may be a correlation factor between allergic purport and kidney disease. Professor WU Kang-heng has acumulated abundant expriences to treat allergic purpttra with chinese medicine, now i will make a introduction.
出处 《辽宁中医药大学学报》 CAS 2011年第9期134-136,共3页 Journal of Liaoning University of Traditional Chinese Medicine
关键词 过敏性紫癜 病因病机 辨证分型 医案举隅 allergic purpura pathogenesis dialectical and differentiation example
  • 相关文献

参考文献2

二级参考文献15

  • 1高玉兴,池永学,李亚荣,尹永杰,刘禹仁.过敏性紫癜白细胞介素2水平及其受体表达[J].中华儿科杂志,1995,33(2):91-92. 被引量:39
  • 2Ortiz A, Gomez-Chiarri M, Alonso J, et al. The potential role of inflammatory and fibrogenic cytokines in the glomerular disease [J] .J Lipid Med Cell,1994,9(1):55-74.
  • 3Dayer J M, Burger D.Interleukin-1,tumor necrosis factor and their specific inhibitor [J] . Eur Cytokine Netw, 1994,5(6):563-571.
  • 4Striker L, Peten E, Elliot S, et al. Mesangial cell turnover:effect of heparin and peptide growth factors [J] . Lab Invest, 1991,64(4):446-456.
  • 5Rostoker G, Rymer JC, Bagnard G ,et al. Imbalances in serum proinflammatory cytokines and theirs soluble receptors:a putative role in the progression of idiopathic IgA nephropathy and Henoch-Schonlein purpura nephritis, and a potential target of immunoglobulin therapy? [J] .Clin Exp Immunol,1998,114(3):468-476.
  • 6Gardner-Medwin J M, Dolezalova P, Cummins C, et al. Incidence of Henoch-Schonlein purpura,Kawasaki disease, and rare vasculitides in children of different ethnic origins [ J ]. Lancet, 2002, 360 (9341) :1197 -202.
  • 7Chang W L,Yang Y H,Wang L C,et al. Renal manifestations in Henoch-Schonlein purpura: a 10-year clinical study [ J]. Pediatr Nephrol,2005, 20(9) : 1269 -72.
  • 8Shin J l,Park J M,Shin Y H,et al. Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Scholein purpura[ J ]. Scand J Rheumatol,2006,35 ( 1 ) :56 - 60.
  • 9Sano H, Izumida M, Shimizu H, et al. Risk factors of renal involvement and significant proteinuria in Henoch-Scholein purpura[ J]. Eur J Pediatr,2002, 161 (4) : 196 - 201.
  • 10Rigante D, Candelli M, Federico G, et al. Predictive factors of renal involvement or relapsing disease in children with Henoch-Scholein purpura[ J]. Rheumatol Int,2005,25 ( 1 ) :45 -8.

共引文献43

同被引文献90

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部